FENC — FENNEC PHARMACEUTICALS INC (Healthcare >> Biotechnology)
FENC FAQ
What is FENC's P/E ratio?
FENNEC PHARMACEUTICALS INC (FENC) currently trades at a P/E ratio of 1,503.54.
What is FENC's ROE?
FENNEC PHARMACEUTICALS INC reports a Return on Equity (ROE) of -22.23%.
What is FENC's dividend yield?
FENNEC PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is FENC's Deepscope Quality Score?
Deepscope rates FENC's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy FENC?
Deepscope's AI Timing Score for FENC is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does FENC belong to?
FENNEC PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 8.70
Price
-0.46
(-5.02%)
Day Change
|
|
|---|
FENC Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) nhưng Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 78 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 8.70 |
| PBV / Sector |
8.02 / 4.63
|
| Earning Per Share | -0.24 |
| PE / Sector |
1,503.54 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
2.37 / 0.53
|
| Average 1M Daily Value |
3.78 M
GREAT
|
| Average 1W Daily Value |
2.46 M
GREAT
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
41% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:09:24 |
| Symbol | FENC |
| Name | FENNEC PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 34.74 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 302.21 / 8,857.28 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
Phone: 919 636 4530
Website: https://www.fennecpharma.com
Sector: Healthcare >> Biotechnology
Description: Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google